Price $0.22 |
Market Cap
14.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.41
|
P/S
2.86
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-21.5K
|
FCF
-0.6
|
|
Op. Margin
-549.80%
|
Net Margin
-561.40%
|
ROE
-444.70%
|
ROI
-452.70%
|
|
ROA
-196.60%
|
EPS Growth
57.30%
|
Current Ratio
0.9
|
Debt/Equity
92.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Allergan plc (AGN) | $173.42 | - | 1.90% | 51.13B | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $23.99 | - | 3.90% | 22.05B | Strong Buy |
| Pernix Therapeutics Holdings I (PTX) | $2.55 | - | - | 27.5M | Strong Buy |
| Valeant Pharmaceuticals Intl I (VRX) | $24.27 | - | - | 7.68B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
